(Q39746487)

14 September 2017

Establishment and identification of the human multi-drug-resistant cholangiocarcinoma cell line QBC939/ADM. (English)

1 reference

14 September 2017

0 references

0 references

multiple drug resistance

1 reference

Zhi-Hua Liu

1

1 reference

14 September 2017

Yan-Ping He

2

1 reference

14 September 2017

Yukun Zhou

3

1 reference

14 September 2017

Peng Zhang

4

1 reference

14 September 2017

Huanlong Qin

5

1 reference

14 September 2017

29 January 2010

1 reference

Molecular Biology Reports

14 September 2017

1 reference

14 September 2017

38

1 reference

14 September 2017

5

1 reference

14 September 2017

3075-3082

1 reference

describes a project that uses

14 September 2017

QBC939

0 references

QBC939/ADM

0 references

exact match

https://scigraph.springernature.com/pub.10.1007/s11033-010-9975-7

0 references

cites work

Biliary tract cancers.

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Intrahepatic cholangiocarcinoma associated with intrahepatic duct stones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Length and quality of survival following external beam radiotherapy combined with expandable metallic stent for unresectable hilar cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Predictive factors for survival of patients with inoperable malignant distal biliary strictures: a practical management guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Changing strategies in diagnosis and management of hilar cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

The epidemiology of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Tissue distribution and induction of human multidrug resistant protein 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Centromere anatomy in the multidrug-resistant pathogen Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Comparative genomics of the IncA/C multidrug resistance plasmid family.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Tadalafil pharmacokinetics in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Hilar cholangiocarcinoma: current management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Antiproliferation and apoptosis induced by tamoxifen in human bile duct carcinoma QBC939 cells via upregulated p53 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Acquired cellular resistance to flavopiridol in a human colon carcinoma cell line involves up-regulation of the telomerase catalytic subunit and telomere elongation. Sensitivity of resistant cells to combination treatment with a telomerase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Anxa2 plays a critical role in enhanced invasiveness of the multidrug resistant human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Adenovirus expressing p27(Kip1) induces growth arrest of lung cancer cell lines and suppresses the growth of established lung cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Gamma-linolenic acid modulates the response of multidrug-resistant K562 leukemic cells to anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Magnetic cell separation using nano-sized bacterial magnetic particles with reconstructed magnetosome membrane.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Phase I, pharmacokinetic, and pharmacodynamic study of AMG 479, a fully human monoclonal antibody to insulin-like growth factor receptor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Caffeic acid phenethyl ester decreases cholangiocarcinoma growth by inhibition of NF-kappaB and induction of apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

Sodium iodide symporter is expressed at the preneoplastic stages of liver carcinogenesis and in human cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-010-9975-7

The growth-inhibition effect of tamoxifen in the combination chemotherapeutics on the human cholangiocarcinoma cell line QBC939.

21 January 2018

1 reference

12 December 2020

Effectiveness of radiation therapy after surgery for hilar cholangiocarcinoma

1 reference

12 December 2020

Function and regulation of ATP-binding cassette transport proteins involved in hepatobiliary transport

1 reference

12 December 2020

P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro.

1 reference

12 December 2020

Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma

1 reference

12 December 2020

Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study

1 reference

12 December 2020

1 reference

12 December 2020

Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms

1 reference

12 December 2020

In favor of the Jarnagin-Blumgart classification

1 reference

12 December 2020

Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage

1 reference

12 December 2020

Treatment strategy for patients with middle and lower third bile duct cancer

1 reference

12 December 2020

10.1007/S11033-010-9975-7

Identifiers

DOI

1 reference

14 September 2017

1 reference